BNTC - Company ID 0001808898
Benitec Biopharma Inc. has filed 298 public company documents between 2020 and 2026. The most frequent type is major company event (73 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 10-Q | Quarterly report | 1mo ago2026-05-14 | 2026-03-31 | View filing |
| 8-K | Major company event | 1mo ago2026-05-14 | 2026-05-14 | View filing |
| 10-K/A | Annual report (amended) | 3mo ago2026-03-20 | 2025-06-30 | View filing |
| 8-K | Major company event | 4mo ago2026-02-12 | 2026-02-12 | View filing |
| 10-Q | Quarterly report | 4mo ago2026-02-12 | 2025-12-31 | View filing |
| 424B3 | 424B3 | 4mo ago2026-02-11 | - | View filing |
| EFFECT | EFFECT | 5mo ago2026-02-10 | - | View filing |
| CORRESP | Company correspondence | 5mo ago2026-02-06 | - | View filing |
| UPLOAD | SEC correspondence | 5mo ago2026-02-06 | - | View filing |
| S-3 | Securities registration | 5mo ago2026-01-30 | - | View filing |
| 4 | Insider trade | 5mo ago2026-01-26 | 2026-01-22 | View filing |
| 4 | Insider trade | 6mo ago2025-12-29 | 2025-12-23 | View filing |
| 4 | Insider trade | 6mo ago2025-12-22 | 2025-12-18 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 7mo ago2025-12-03 | - | View filing |
| 4 | Insider trade | 7mo ago2025-12-03 | 2025-12-01 | View filing |
| 4 | Insider trade | 7mo ago2025-12-03 | 2025-12-01 | View filing |
| 4 | Insider trade | 7mo ago2025-12-03 | 2025-12-01 | View filing |
| 4 | Insider trade | 7mo ago2025-12-03 | 2025-12-01 | View filing |
| 4 | Insider trade | 7mo ago2025-12-03 | 2025-12-01 | View filing |
| 8-K | Major company event | 7mo ago2025-12-02 | 2025-12-01 | View filing |
| 4 | Insider trade | 7mo ago2025-11-20 | 2025-11-18 | View filing |
| 4 | Insider trade | 7mo ago2025-11-20 | 2025-11-18 | View filing |
| 4 | Insider trade | 7mo ago2025-11-20 | 2025-11-18 | View filing |
| 8-K | Major company event | 7mo ago2025-11-14 | 2025-11-14 | View filing |
| 10-Q | Quarterly report | 7mo ago2025-11-14 | 2025-09-30 | View filing |
| DEFA14A | Proxy materials | 8mo ago2025-11-12 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 8mo ago2025-11-10 | - | View filing |
| 4 | Insider trade | 8mo ago2025-11-10 | 2025-11-07 | View filing |
| 8-K | Major company event | 8mo ago2025-11-07 | 2025-11-05 | View filing |
| 424B5 | Prospectus supplement | 8mo ago2025-11-07 | - | View filing |
| 4 | Insider trade | 8mo ago2025-11-07 | 2025-11-05 | View filing |
| 3 | New insider ownership | 8mo ago2025-11-07 | 2025-11-03 | View filing |
| 424B5 | Prospectus supplement | 8mo ago2025-11-05 | - | View filing |
| 8-K | Major company event | 8mo ago2025-11-03 | 2025-11-02 | View filing |
| DEFA14A | Proxy materials | 8mo ago2025-10-14 | - | View filing |
| DEF 14A | Proxy statement | 8mo ago2025-10-14 | 2025-12-01 | View filing |
| EFFECT | EFFECT | 9mo ago2025-09-29 | - | View filing |
| CORRESP | Company correspondence | 9mo ago2025-09-26 | - | View filing |
| UPLOAD | SEC correspondence | 9mo ago2025-09-25 | - | View filing |
| S-3 | Securities registration | 9mo ago2025-09-22 | - | View filing |
| 8-K | Major company event | 9mo ago2025-09-22 | 2025-09-22 | View filing |
| 10-K | Annual report | 9mo ago2025-09-22 | 2025-06-30 | View filing |
| 8-K | Major company event | 10mo ago2025-09-12 | 2025-09-10 | View filing |
| 8-K | Major company event | 1y ago2025-07-09 | 2025-07-09 | View filing |
| EFFECT | EFFECT | 1y ago2025-06-02 | - | View filing |
| 424B3 | 424B3 | 1y ago2025-06-02 | - | View filing |
| CORRESP | Company correspondence | 1y ago2025-05-29 | - | View filing |
| UPLOAD | SEC correspondence | 1y ago2025-05-29 | - | View filing |
| S-3 | Securities registration | 1y ago2025-05-23 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-15 | - | View filing |